Teladoc Health, Inc. TDOC
6.09
(0.05)
(0.81%)
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow TDOC
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (12.99%) | (12.39%) | (13.93%) | (15.42%) |
+8 more TTM periods Free account |
|
| (6.28%) | (5.48%) | (6.28%) | (6.98%) | ||
ROIC |
(7.62%) | (8.07%) | (10.27%) | (10.36%) | |
Return on Tangible Assets |
85.01% | (22.71%) | (27.02%) | (31.29%) | |
Average Days of Receivables |
32.40 | 31.01 | 27.82 | 30.43 | |
Free Cash Flow per Share |
0.49 | 0.87 | 0.78 | 0.61 | |
Free Cash Flow |
88.56 | 156.26 | 137.33 | 108.31 | |
Capital Expenditures |
(172.62) | (131.69) | (157.02) | (184.20) | |
Piotroski F-Score |
4.00 | 6.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
8.48% | 9.34% | 9.31% | 9.40% | |
Accounts Receivable Turnover |
11.15 | 11.26 | 12.43 | 11.96 | |
Accounts Payable Turnover |
16.81 | 15.88 | 19.03 | 16.97 | |
Inventory Turnover |
23.07 | 22.20 | 20.21 | 19.86 | |
Average Days of Payables |
17.71 | 21.36 | 22.69 | 24.95 | |
Days of Inventory on Hand |
13.62 | 14.91 | 18.07 | 19.08 | |
Tax Rate |
(0.03) | (0.08) | (0.15) | (0.11) | |
Research and Development Expense of Revenue |
10.84% | 10.97% | 10.99% | 11.20% | |
Selling, General and Administrative Expense of Revenue |
49.26% | 49.91% | 50.58% | 51.48% | |
Share Based Compensation of Revenue |
2.28% | 2.78% | 3.18% | 3.64% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(1.47) | (1.68) | (1.47) | (1.31) | |
Depreciation/Fixed assets |
15.82 | 14.96 | 16.62 | 16.37 | |
Capex/Depreciation |
(0.44) | (0.33) | (0.35) | (0.42) | |
Revenue per Share |
13.75 | 14.04 | 14.36 | 14.29 | |
Operating CF per Share |
1.44 | 1.61 | 1.67 | 1.65 | |
Capex per Share |
(0.95) | (0.74) | (0.89) | (1.04) | |
Capex to Sales |
0.07 | 0.05 | 0.06 | 0.07 | |
Net Profit Margin |
(7.13%) | (6.81%) | (7.92%) | (8.84%) |
Columns are period end dates